Serum C-reactive protein levels predict survival in hepatocellular carcinoma

Autor:	Takuji Torimura, Tsutomu Imaizumi, Jun Akiba, Hironori Koga, Takafumi Yoshida, Masamichi Kojiro, Hisashi Adachi, Junichi Kurogi, Takashi Niizeki, Junji Akiyoshi, Nobuyoshi Tajiri, Kinya Inoue, Michio Sata, Sakae Nagaoka
Rok vydání:	2007
Předmět:	Adult Male Pathology medicine.medical_specialty Carcinoma Hepatocellular Time Factors Adolescent Kaplan-Meier Estimate Risk Assessment Gastroenterology Internal medicine Biomarkers Tumor medicine Humans Transcatheter arterial chemoembolization Survival rate Aged Neoplasm Staging Proportional Hazards Models Retrospective Studies Aged 80 and over Univariate analysis Hepatology biology business.industry Proportional hazards model Liver Neoplasms C-reactive protein Hazard ratio Retrospective cohort study Middle Aged medicine.disease C-Reactive Protein Treatment Outcome Hepatocellular carcinoma Multivariate Analysis biology.protein Female business Follow-Up Studies
Zdroj:	Liver International. 27:1091-1097
ISSN:	1478-3231 1478-3223
Popis:	Background/Aims: C-reactive protein (CRP) was recently identified as a prognostic factor for patients with hepatocellular carcinoma (HCC) after surgical resection. We investigated the relationship between the serum levels of high sensitivity CRP (H-CRP) and the prognosis of HCC patients. Method: We conducted a cohort study of 90 HCC patients enrolled from 1997 to 1998. All patients were treated and followed for a mean period of 3.2 years. Clinical variables were compared between patients positive for H-CRP (serum H-CRP levels ≥3.0 mg/L, n=47) and those negative for H-CRP (serum H-CRP levels
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58c2da217c117f53abffe76fb36116bc https://doi.org/10.1111/j.1478-3231.2007.01550.x Zobrazit plný text záznamu Plný text ve formátu PDF